TRxADE HEALTH (MEDS) Short Interest Ratio & Short Volume → Missed NVDA? Buy this AI stock NOW (From Chaikin Analytics) (Ad) Free MEDS Stock Alerts $5.70 +0.08 (+1.42%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media TRxADE HEALTH Short Interest DataCurrent Short Volume12,200 sharesPrevious Short Volume20,500 sharesChange Vs. Previous Month-40.49%Dollar Volume Sold Short$72,712.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares1,410,000 sharesFloat Size990,600 sharesShort Percent of Float1.23%Today's Trading Volume15,418 sharesAverage Trading Volume13,706 sharesToday's Volume Vs. Average112% Short Selling TRxADE HEALTH ? Sign up to receive the latest short interest report for TRxADE HEALTH and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMEDS Short Interest Over TimeMEDS Days to Cover Over TimeMEDS Percentage of Float Shorted Over Time Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. TRxADE HEALTH Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202412,200 shares $72,712.00 -40.5%1.2%0 $5.96 4/15/202420,500 shares $149,650.00 -39.7%2.4%0 $7.30 3/31/202434,000 shares $348,160.00 -39.3%4.0%0.1 $10.24 3/15/202456,000 shares $1.61 million +80.7%6.6%0.1 $28.80 2/29/202431,000 shares $295,120.00 +171.9%3.7%0.1 $9.52 2/15/202411,400 shares $51,072.00 -9.5%1.3%0.1 $4.48 Get the Latest News and Ratings for MEDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. 1/31/202412,600 shares $52,542.00 -13.1%1.5%1.3 $4.17 1/15/202414,500 shares $70,760.00 +48.0%1.7%1.8 $4.88 12/31/20239,800 shares $50,923.74 -36.8%N/A0.9 $5.20 12/15/202315,500 shares $85,250.00 +12.3%1.7%1.3 $5.50 11/30/202313,800 shares $82,110.00 +32.7%1.5%0.7 $5.95 11/15/202310,400 shares $61,568.00 -12.6%1.2%0 $5.92 10/31/202311,900 shares $69,258.00 +38.4%1.3%0 $5.82 10/15/20238,600 shares $59,942.00 -30.1%1.0%0 $6.97 9/30/202312,300 shares $86,469.00 -12.1%1.4%0 $7.03 9/15/202314,000 shares $111,580.00 +125.8%1.6%0 $7.97 8/31/20236,200 shares $47,368.00 +1.6%1.0%0 $7.64 8/15/20236,100 shares $47,397.00 +10.9%1.0%0 $7.77 7/31/20235,500 shares $40,810.00 -63.1%1.4%0 $7.42 7/15/202314,900 shares $155,854.00 -88.4%4.5%0 $10.46 6/30/2023128,500 shares $1.68 million +1,377.0%38.5%0.3 $13.05 6/15/20238,700 shares $43,065.00 -90.6%2.6%0 $4.95 5/31/202392,900 shares $26,012.00 +1.6%1.9%0.2 $0.28 5/15/202391,400 shares $36,048.16 +140.5%1.9%0.6 $0.39 4/30/202338,000 shares $12,697.74 -45.7%0.8%0.2 $0.33 4/15/202370,000 shares $20,804.00 -6.8%1.3%0.3 $0.30 3/31/202375,100 shares $22,154.50 +39.9%1.5%0.2 $0.30 3/15/202353,700 shares $19,332.00 +13.8%1.2%0.1 $0.36 2/28/202347,200 shares $19,663.52 +76.1%1.0%0.1 $0.42 2/15/202326,800 shares $10,452.00 -68.2%0.6%0.1 $0.39 1/31/202384,200 shares $35,380.84 -36.0%1.8%0.2 $0.42 1/15/2023131,500 shares $53,310.10 +73.0%2.8%0.6 $0.41 12/30/202276,000 shares $30,597.60 -31.9%1.6%0.4 $0.40 12/15/2022111,600 shares $55,253.16 +12.6%2.3%4.4 $0.50 11/30/202299,100 shares $55,991.50 +3.1%2.1%0.2 $0.57 11/15/202296,100 shares $68,970.97 +14.3%2.0%0.2 $0.72 10/31/202284,100 shares $74,849.00 -10.7%2.0%0.2 $0.89 10/15/202294,200 shares $85,486.50 -36.5%2.7%0.2 $0.91 9/30/2022148,400 shares $167,692.00 +108.4%4.2%0.3 $1.13 9/15/202271,200 shares $82,592.00 -59.6%2.3%0.1 $1.16Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. MEDS Short Interest - Frequently Asked Questions What is TRxADE HEALTH's current short interest? Short interest is the volume of TRxADE HEALTH shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 12,200 shares of MEDS short. 1.23% of TRxADE HEALTH's shares are currently sold short. Learn More on TRxADE HEALTH's current short interest. What is a good short interest percentage for TRxADE HEALTH? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.23% of TRxADE HEALTH's floating shares are currently sold short. Is TRxADE HEALTH's short interest increasing or decreasing? TRxADE HEALTH saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 12,200 shares, a decrease of 40.5% from the previous total of 20,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TRxADE HEALTH's float size? TRxADE HEALTH currently has issued a total of 1,410,000 shares. Some of TRxADE HEALTH's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TRxADE HEALTH currently has a public float of 990,600 shares. How does TRxADE HEALTH's short interest compare to its competitors? 1.23% of TRxADE HEALTH's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TRxADE HEALTH: Cosmos Health Inc. (2.28%), BIMI Holdings Inc. (2.92%), AquaBounty Technologies, Inc. (4.29%), Cyclerion Therapeutics, Inc. (0.99%), ProSomnus, Inc. (1.18%), Trevena, Inc. (0.08%), Vaxxinity, Inc. (3.61%), Bionomics Limited (1.45%), XWELL, Inc. (1.78%), Psyence Biomedical Ltd. (5.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short TRxADE HEALTH stock? Short selling MEDS is an investing strategy that aims to generate trading profit from TRxADE HEALTH as its price is falling. MEDS shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TRxADE HEALTH? A short squeeze for TRxADE HEALTH occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDS, which in turn drives the price of the stock up even further. How often is TRxADE HEALTH's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Cosmos Health Short Squeeze BIMI Short Squeeze AquaBounty Technologies Short Squeeze Cyclerion Therapeutics Short Squeeze ProSomnus Short Squeeze Trevena Short Squeeze Vaxxinity Short Squeeze Bionomics Short Squeeze XWELL Short Squeeze Psyence Biomedical Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MEDS) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits